ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy

ClinicalTrials.gov ID: NCT06604442

Public ClinicalTrials.gov record NCT06604442. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 3:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT06604442
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Blue Earth Diagnostics
Industry
Enrollment
62 participants

Conditions and interventions

Interventions

  • flotufolastat (18F) Drug
  • piflufolastat (18F) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 3, 2024
Primary completion
Aug 28, 2025
Completion
Aug 28, 2025
Last update posted
May 11, 2026

2024 – 2025

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Mayo Clinic Phoenix Arizona 85054
City of Hope Medical Center Duarte California 91010
Tower Urology Los Angeles California 90048
Mayo Clinic Jacksonville Florida 32224
Endeavor Health- Glenbrook Hospital Glenview Illinois 60026
XCancer Omaha/Urology Cancer Center Omaha Nebraska 68130
Montefiore Medical Center The Bronx New York 10461
Cleveland Clinic Cleveland Ohio 44195
Urology San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06604442, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2026 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06604442 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →